MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611059943 A) filed by Noida Institute Of Engineering And on May 12, 2026, for A Controlled Release Oral Suspension Formulation.
Inventors include Archna Singh; and Dr. Anjna Rani.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: A controlled release oral suspension formulation is disclosed for administering an active pharmaceutical ingredient in liquid form while providing sustained gastrointestinal release. The formulation comprises a suspension vehicle containing dispersed release units, each having a drug core and a release-controlling layer. A suspending network maintains redispersibility, while a palatability system improves oral acceptability. The vehicle may include buffer, osmotic modifier, preservative, and wetting agent to protect stability. The formulation enables accurate volume-based dosing for patients requiring non-solid controlled release therapy.
Disclaimer: Curated by HT Syndication.
